Armistice Capital, LLC 13D and 13G filings for Citius Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 10:09 am Purchase | 2026-06-30 | 13G | CITIUS ONCOLOGY INC CTOR | Armistice Capital, LLC | 9,353,553 9.990% | 53,636 (+0.58%) | Filing |
| 2026-05-15 11:11 am Purchase | 2026-03-31 | 13G | CITIUS ONCOLOGY INC CTOR | Armistice Capital, LLC | 9,299,917 9.990% | 1,221,513 (+15.12%) | Filing |
| 2026-02-17 9:52 pm Purchase | 2025-12-31 | 13G | CITIUS ONCOLOGY INC CTOR | Armistice Capital, LLC | 8,078,404 9.990% | 402,493 (+5.24%) | Filing |
| 2025-11-14 6:41 pm Purchase | 2025-09-30 | 13G | CITIUS ONCOLOGY INC CTOR | Armistice Capital, LLC | 7,675,911 9.790% | 7,675,911 (New Position) | Filing |